Chemistry

Selecting the Right European Location for Life Sciences Activities

Agile and resilient: This is how manufacturers in the life sciences industry could be described during the Covid-19 pandemic. As disruption took hold in many other industries’ supply chains, life ­sciences companies moved to rapidly develop new products and build new capacity. They are maintaining this momentum, with pharmaceutical and biotech businesses showing continued interest in expanding existing operations in Europe or starting operations from scratch.

The Future of Biopharma

Porsche Consulting presents a vision of a high-end smart biopharmaceutical production unit and a corresponding operating model.

Working with Data Instead of Documents

Cloud-based web applications offer substantial benefits for the digital transformation of the chemical industry.

Fine Chemicals in China

Fu Xiangsheng, Vice Chairman of the China Petroleum and Chemical Industry Federation, characterized China`s chemical industry as having a a surplus of basic chemicals and a shortage of functional chemicals. Indeed, the share of fine chemicals as a percentage of the total industry value is only about 45% compared to 60-70% in the US and in many European countries, and 90% in Switzerland. Thus, the Chinese government is interested in supporting the development of local fine chemicals production.

Mergers & Acquisitions Are an Integral Strategic Component

In the drive to reach growth objectives, or to maintain and enhance “critical mass”, mergers & acquisitions (M&A) has been a theme for the chemical distribution industry for years. The industry leaders (by size and geographic reach) were all built through a series of such transactions. The practice is further trickling down to the smaller and mid-sized company layer of the sector, and more distributors espouse external growth options.

Small, Modular Flow Plants

In 2020, the weakness associated with global chemical supply chains was highlighted in a dramatic manner as Covid-19 was designated a global pandemic. As a result, small modular continuous flow plants are gaining attention as an appropriate solution to secure supply chains whilst ensuring safe, sustainable processes are implemented.

Sustainable Synthesis of Biochemicals

When Circa was founded in 2006, the company’s aim was to convert non-food cellulose into high-performance, renewable chemicals, at scale — extracting value from waste biomass and addressing a gap in the market for better, more sustainable materials.

Is the Beauty Industry Sending the Wrong Message?

As gender and diversity, as well as the body positivity movement, become more and more prevalent among young consumers, beauty companies are finding that they are going to have to re-define how products are advertised if they want to stay relevant.

Solution Partner on the Road to Success

Yiğitoğlu, the family-run Turkish chemical manufacturing, distribution and logistics services group that started commercial activities in 1956, has set out to expand its geographic footprint.

Integrating Science and Creativity

Dago Caceres, Global Strategy Manager for Pharma Solutions at IFF, talks about the new IFF and the strategy ahead for the pharmaceutical division in particular.

M&A Activity Will Continue, No Doubt!

Analysis of the mergers & acquisitions activity in chemical distribution under the impression of the pandemic situation and how it might develop going forward.

The Age of Sustainability

In a nutshell, reaching sustainability has become a key aspect for chemical companies and adjacent businesses along the product chain with a high entry hurdle for everyone.

Innovation and Creativity in the Pharmaceutical Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special Recognition Awards for Operational Agility: Covid-19 Impact.

Pharma 4.0: Smart Manufacturing

Marcus Michel, CEO of ACG Engineering, analyzes market trends in pharmaceutical engineering and manufacturing.

Streamlining the Path to Peptide Market Supply

Interview with Michael Postlethwaite, Senior Director, Sales & Business Development, European Territories, AmbioPharm

Advancing Scientific Breakthroughs

Interview with Christophe Couturier and Claudia Berrón, Avantor

Recycled and Carbon-neutral Precious Metals

Over the years, sustainability has evolved from an aspirational goal to an operational priority. Companies in every industry are being asked to incorporate more environmental stewardship into their operations and business practices.

Innovation is the Driver to Delivering Value

Michael Reubold talked to Evonik’s Sanjeev Taneja about the role of catalysts in the company and their value to the industry and the society.

Expanding Into Oligonucleotides

The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this competitive environment in 2019.

High Quality and Flexibility for Pharmaceutical Customers

WeylChem’s Custom Manufacturing division has a strong record of accomplishments operating in markets such as Pharma, Agro and Pigments.

A Virtual Formulation Assistant

BASF has created ZoomLab, a virtual formulation prediction and optimization tool, to help address the challenges of drug product development.

Challenges Facing Pharmaceutical Manufacturing

Sean Diver, president of DCAT speaks about the pharmaceutical industry’s role during the Covid-19 pandemic, trends in drug manufacturing, and key issues for the EU pharmaceutical industry.

Understanding the Requirements of Safe HPAPI Manufacturing

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable targets for oncology and other areas.

The Rise of HPAPI Molecules

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

The Impact of Covid-19 on the Pharmaceutical Industry

Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma market.

CheMondis Webinars

As a fully digital player in the chemical industry, CheMondis regularly offers webinars for buyers and suppliers.

Expert Webinar: Accelerating Process Development with Design of Experiments

Synthace’s multidisciplinary team of researchers and software engineers have developed the Antha software platform to lower the barriers for scientists to execute sophisticated experiments with automated laboratory equipment.

Upcycling of Post-Consumer PLA Waste

Designed for their performance and durability, synthetic plastics have become indispensable as “materials of every-day use”. However, their characteristic long life span and indiscriminate disposal have led to an acute problem of plastic pollution. In order to address this issue, the European Union is not only trying to adopt a circular system to reuse, repair and recycle plastics (circular economy) but it also aims to produce plastics out of renewable resources (biobased plastics).

Circular Economy for Polymers in Liquid Formulated Products

Contributing to the Circular Economy

Cellugy was founded two years ago by a diverse team of young academics and professionals from Spain, Indonesia, Albania, and Denmark. Working together at Aarhus University in Denmark, the idea of developing a material based on nanocellulose as an alternative to plastic barrier coatings arose and grew into a start-up and a first product. Co-founders Isabel Alvarez-Martos and Deby Fapyane talk about their motivation and vision.

A New Responsible Way of Doing the Chemical Distribution Business

Moving from a Linear Economy to a Circular Economy

The Age Of Circularity

Experts Statements: Philippe Robin, Alysophil

The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.

Experts Statements: André de Vries, Innosyn

The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.